Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-48
SponsorAretaieion University Hospital

About this trial

This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adult parturients, American Society of Anesthesiologists (ASA) I-II,

singleton gestation>37 weeks

elective cesarean section

Disqualifiers

American Society of Anesthesiologists (ASA) > III

age < 18 years

singleton gestation <37 weeks

Body Mass Index (BMI) >40 kg/m2

Trial design

Design model

Parallel

Treatments tested in this trial

  • Chloroprocaine 1% Injectable Solution

    Drug

    • in parturients allocated to the chloroprocaine group, a fixed dose of chloroprocaine 1% will be administered intrathecally

  • Ropivacaine 0.75% Injectable Solution

    Drug

    • in parturients allocated to the ropivacaine group, a fixed dose of ropivacaine 0.75% will be administered intrathecally

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: chloroprocaine groupActive comparator 1 intervention
Group B: ropivacaine groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time from spinal anesthesia to T10 block (min)

time required from spinal anesthetic injection to anesthetic block up to the 10th thoracic neurotome

Time frame
intraoperative
2

Time from spinal anesthesia to T4 block (min)

time required from spinal anesthetic injection to anesthetic block up to the 4th thoracic neurotome

Time frame
intraoperative
3

Time of spinal anesthesia to Bromage =3

time required from spinal anesthetic injection to complete motor block (Bromage scale=3, where Bromage=0, no block; Bromage=1, partial block; Bromage=2, almost complete block; Bromage=3, complete block

Time frame
intraoperative
4

level of sensory block every 3 min

measurement of sensory block every 3 minutes after spinal anesthesia during the first 15 minutes

Time frame
intraoperative

Secondary outcomes

1

Neonatal Apgar score at 1 minute

Neonatal Apgar score will be recorded at 1 minute after delivery. The Apgar score is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts

Time frame
1 minute post delivery
2

Neonatal Apgar score at 5 minutes

Neonatal Apgar score will be recorded at 5 minutes after delivery. The Apgar score is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts

Time frame
1 minute post delivery
3

neonatal blood gases

fetal cord blood analysis will be performed immediately post-delivery

Time frame
1 minute post delivery
4

incidence of neonatal acidosis

incidence of neonatal acidosis (PH\<7.2) will be recorded

Time frame
1 minute post delivery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.